Third, although we found the three variants in P53, MDM‐2, and MMP‐9 could synergistically contribute to a higher risk of ND and poor functional outcome, we did not investigate the molecular mechanisms of the gene–gene interactions. This evidence concerns the gene TP53 and Norrie disease.